surmount-1 tirzepatide weight loss non-diabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial SURMOUNT‐1 study design. This is

Some practitioners employ intermediate dose increases, such as escalating by 0.25 mg increments rather than doubling doses, to improve tolerance in sensitive patients

The basal serum levels of FSH and luteinizing hormone (LH), anti-Mullerian hormone (AMH), thyroid stimulating hormone (TSH) as well as free testosterone and dehydroepiandrosterone sulphate (DHEAS) concentrations were measured in a venous blood sample collected from all participants on the day 2 or 3 of their menstrual cycle

RIPK3, receptor-interacting protein kinase 3

Semaglutide works by targeting the GLP-1 receptor pathway

Combining peptide medicine with nervous system regulation helps stabilise mood, reduce anxiety, and sustain behaviour change, making it easier to maintain a healthy lifestyle long-term